Heroin addiction is a form of opioid use disorder (OUD) involving a problematic pattern of heroin use that causes significant impairment or distress.
Treatment is available, and it does not follow one standard path for everyone. Depending on the person's withdrawal risk, health, mental health, overdose history, living environment, and treatment goals, care may include medications for opioid use disorder, withdrawal management, inpatient or outpatient treatment, counseling, mental health services, overdose prevention, and continuing support.
Three FDA-approved medications used for OUD are buprenorphine, methadone, and naltrexone. Medication treatment is associated with lower overdose and overall mortality risk and should be considered a core evidence-based treatment option rather than simply a short-term detox tool. CDC
Learn more about opioid addiction treatment →
Heroin addiction is treated as opioid use disorder. Evidence-based treatment can include buprenorphine, methadone, or naltrexone, along with medical care, counseling, behavioral treatment, mental health services, overdose-prevention planning, and recovery support.
Some people need medically supported withdrawal management at the beginning of treatment, while others may begin medication or outpatient care without completing a separate residential detox program.
The appropriate setting can range from residential rehab to intensive outpatient care, standard outpatient services, primary care, or an opioid treatment program.
Most importantly, detox alone should not be treated as complete OUD treatment. CDC advises against detoxification without ongoing medication treatment because of increased risks of returning to opioid use, overdose, and overdose death. CDC
Heroin is an illicit opioid derived from morphine. Repeated use can lead to tolerance, physical dependence, and opioid use disorder.
A person with heroin-related OUD may find it increasingly difficult to control use despite problems involving health, relationships, work, finances, safety, or other parts of life.
Possible signs can include using more than intended, unsuccessful attempts to stop, strong cravings, spending significant amounts of time obtaining or recovering from heroin, and continuing use despite serious consequences.
Physical dependence alone is not the same as addiction. Withdrawal can occur when the body has adapted to opioids, while OUD involves a broader pattern of problematic use and impairment.
Someone does not need to diagnose themselves before seeking an assessment.
According to SAMHSA's 2024 National Survey on Drug Use and Health, approximately 556,000 people aged 12 or older reported heroin use during the past year. SAMHSA's detailed 2024 tables estimate that approximately 496,000 people aged 12 or older had a heroin use disorder during the past year. SAMHSA
Final CDC data recorded 2,743 U.S. overdose deaths involving heroin in 2024, down from 3,984 in 2023. Deaths can involve more than one drug, so these categories should not be interpreted as mutually exclusive. CDC
Today's heroin risk also cannot be separated completely from fentanyl. Illegally manufactured fentanyl can be added to or sold with other illicit drugs, increasing the chance of unexpected exposure to a much more potent opioid. CDC
Treatment should begin with an assessment rather than automatically sending everyone to the same rehab program.
A treatment professional may ask about heroin and other opioid use, possible fentanyl exposure, withdrawal symptoms, previous overdose, medications, physical health, mental health, previous treatment, other substances, housing, support, and treatment goals.
This information helps determine both the appropriate level of care and whether medication treatment should begin.
One person may need medical withdrawal management and residential treatment. Another may be able to begin buprenorphine in an outpatient setting. Someone else may need an opioid treatment program for methadone.
Repeated heroin use can produce physical dependence. When heroin use stops or decreases substantially, withdrawal symptoms may occur.
Symptoms can include anxiety, restlessness, sweating, muscle aches, difficulty sleeping, stomach discomfort, nausea, vomiting, diarrhea, and strong opioid cravings.
Withdrawal experiences differ from person to person and may be affected by other substances, fentanyl exposure, medications, health conditions, and the pattern of opioid use.
Because of this variation, a fixed “day-by-day heroin withdrawal timeline” should not be treated as universally accurate.
Withdrawal management may involve medical monitoring, supportive care, and medication when appropriate.
No.
Withdrawal management can help someone become medically stable and get through immediate withdrawal.
After detox, cravings, triggers, mental health symptoms, unstable housing, other substance use, and overdose risks may remain.
One of the most important risks after a period without opioids is loss of tolerance. An amount of heroin or another opioid that someone previously tolerated may become much more dangerous after a period of reduced or no use.
This is one reason treatment should connect withdrawal management directly to medication, behavioral care, recovery support, and overdose-prevention planning rather than treating detox as the finish line.
Heroin addiction is treated with the same FDA-approved medications used for opioid use disorder generally: buprenorphine, methadone, and naltrexone. CDC
Buprenorphine is a partial opioid agonist that can reduce withdrawal and cravings.
It can be prescribed through a variety of healthcare settings. Federal rules that once required a special X-waiver to prescribe buprenorphine for OUD have been removed, although practitioners still must follow applicable professional, federal, and state requirements.
Methadone is a full opioid agonist used in OUD treatment to reduce withdrawal and cravings and support stabilization.
In the United States, methadone used specifically to treat OUD is generally provided through certified opioid treatment programs, or OTPs. SAMHSA
Naltrexone works differently by blocking opioid receptors rather than activating them.
Extended-release injectable naltrexone is approved for OUD. Because opioids need to be cleared appropriately before naltrexone begins, treatment initiation should be managed by a qualified healthcare professional.
No.
Methadone and buprenorphine are opioid medications, but taking an evidence-based medication under clinical care is not the same as uncontrolled heroin use.
These medications are used in structured treatment to reduce withdrawal and cravings, support stability, and lower important health risks.
Physical dependence can occur with opioid medications, but physical dependence and addiction are not identical concepts.
The goal of treatment is improved health, functioning, safety, and control over opioid use—not simply whether a medication activates an opioid receptor.
Medication can address withdrawal, cravings, and other biological aspects of opioid use disorder.
Counseling and behavioral services can help address different parts of recovery, including triggers, stress, relationships, decision-making, routines, trauma, mental health symptoms, and strategies for maintaining stability.
Treatment may involve individual counseling, group treatment, motivational approaches, cognitive and behavioral strategies, family services, peer support, or case management.
However, medication should not automatically be withheld because counseling is temporarily unavailable. Modern OUD care should be individualized rather than forcing every patient through exactly the same treatment sequence.
Not everyone with heroin-related OUD needs residential rehab.
Inpatient or residential treatment may be useful when someone needs greater structure, has significant medical or mental health needs, has an unstable living situation, or requires support that cannot be provided safely in the community.
Outpatient treatment allows someone to remain outside the facility while attending scheduled care.
Depending on the setting, outpatient heroin treatment may include buprenorphine or naltrexone, counseling, psychiatric care, medical appointments, telehealth, and recovery support.
Methadone is somewhat different because OUD treatment with methadone is generally delivered through certified OTPs.
Depression, anxiety, PTSD, bipolar disorder, and other mental health conditions can occur alongside opioid use disorder.
Mental health symptoms can affect substance use, medication adherence, sleep, safety, relationships, and treatment participation.
When both conditions are present, care may involve addiction medication, psychotherapy, psychiatric services, case management, or other coordinated support.
Someone seeking treatment for heroin use may also have been exposed to fentanyl.
CDC notes that illegally made fentanyl is commonly found in the illicit drug supply and is a major contributor to fatal and nonfatal overdose. Fentanyl can be far more potent than heroin. CDC
This matters during assessment because the treatment team should understand recent opioid exposure, overdose history, withdrawal, and possible fentanyl involvement.
Heroin can dangerously slow breathing during an overdose.
Naloxone is a medication that can temporarily reverse an opioid overdose, including overdoses involving heroin or fentanyl.
People with OUD, their household members, and close support people may benefit from having naloxone available and knowing how to use it.
Overdose-prevention planning is particularly important after periods of abstinence or reduced opioid use because tolerance can decrease.
Naloxone is an emergency intervention. It does not replace ongoing opioid use disorder treatment.
There is no single correct treatment length.
Someone may begin with withdrawal management, move into residential care, and then continue with outpatient medication and counseling.
Another person may begin directly with community-based medication treatment and never require residential rehab.
Medications such as methadone or buprenorphine may continue for months, years, or longer when they remain beneficial.
Treatment duration should be based on individual needs and progress rather than an arbitrary 30-, 60-, or 90-day deadline.
A treatment program should be able to explain how it evaluates opioid use disorder and determines the appropriate level of care.
One of the most important questions is whether the program provides or coordinates evidence-based medication.
Ask how the facility handles buprenorphine, methadone, and naltrexone when clinically appropriate.
Ask how withdrawal is assessed and medically supported when needed.
Ask whether naloxone education and overdose-risk planning are included.
Ask how co-occurring psychiatric and behavioral-health needs are addressed.
Ask how medication, counseling, and recovery support continue after discharge.
Simply advertising “heroin rehab” does not explain whether the facility follows current evidence-based OUD treatment practices.
Insurance may cover some or many components of heroin addiction treatment, but exact benefits depend on the plan.
Residential treatment, outpatient care, OTP services, physician visits, counseling, medications, and mental health treatment may be processed differently.
Network status, medical-necessity criteria, prior authorization, deductibles, copayments, and coinsurance can all affect what someone ultimately pays.
Readers who are comparing benefits can use the site's verify insurance for rehab resource before making treatment decisions.
Yes. Heroin-related opioid use disorder is treatable with evidence-based medications, behavioral healthcare, overdose prevention, and different levels of treatment according to individual needs.
Buprenorphine, methadone, and naltrexone are FDA-approved medication options for opioid use disorder. CDC
No. Detox addresses withdrawal, but CDC advises against relying on detoxification alone without ongoing OUD medication treatment because of increased risks of resumed use and overdose.
No. Treatment can occur in residential, outpatient, opioid-treatment-program, primary-care, and other settings depending on individual needs.
Buprenorphine-containing medications, including buprenorphine/naloxone products, can be used to treat opioid use disorder involving heroin.
Yes. Methadone is an evidence-based medication used to treat opioid use disorder and is generally provided for OUD through certified opioid treatment programs.
Opioid withdrawal can be extremely uncomfortable and other health conditions or substance use can complicate the situation. Anyone concerned about withdrawal should discuss it with a qualified healthcare professional rather than relying on a generic online detox schedule.
A period without opioids can reduce tolerance. Returning to an amount previously tolerated can therefore increase overdose risk.
Illicit opioid products may contain fentanyl, and a person may not know exactly what is present in the drug supply. CDC
Give naloxone if available and call 911 immediately.
You do not need to know whether medication, detox, inpatient rehab, or outpatient treatment is the right starting point before asking about available care.
Treatment can be explored based on heroin and other opioid use, withdrawal risk, overdose history, possible fentanyl exposure, physical and mental health, recovery environment, location, and insurance circumstances.
This page provides general educational information about heroin, opioid use disorder, withdrawal, treatment medications, rehab, and overdose prevention.
It is not medical advice and should not be used to diagnose OUD, determine medication doses, begin or stop treatment, or create a self-directed detox plan.
Questions about heroin withdrawal, medications, pregnancy, mental health symptoms, or treatment decisions should be discussed with appropriately qualified healthcare professionals.
For a mental health, suicide, or substance-use crisis in the United States, call or text 988.
